InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,320.04
(
0.36%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
74.45
(
-0.22%
)
Bitcoin
60,766.30
(
0.24%
)
Post# of 13962
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Mikefbi

Send PM Follow Ignore
Followers 1
Posts 426
Boards Moderated 0
Alias Born 06/10/2018

Mikefbi

Re: None

Wednesday, 10/23/2019 11:01:10 PM

Wednesday, October 23, 2019 11:01:10 PM

Post# of 13962
Order Approving Immune Pharmaceuticals Inc. and Immune Pharmaceuticals, Ltd.Memorandum of Understanding with the Committee and the Israeli Trustee Relating to the Allocation of Sale Proceeds from the Sale of the Anti-Eotaxin Assets (Related Doc # [327]). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 10/23/2019. (mcp)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up